Cargando…
Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is the third cause of cancer-related deaths worldwide. L antigen family member 3 (LAGE3) is a prognostic biomarker and associated with progression in a variety of tumors. However, little has been reported about the role and potential mechanism of LAGE3 in H...
Autores principales: | Chen, Qianhui, Lu, Xinyu, Xie, Jiayi, Ma, Na, Xu, Weikang, Zhang, Zhiming, Huang, Xuan, Liu, Hongyan, Hou, Jinlin, Zhang, Xiaoyong, Zhu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008773/ https://www.ncbi.nlm.nih.gov/pubmed/35433409 http://dx.doi.org/10.3389/fonc.2022.813275 |
Ejemplares similares
-
Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Weikang, et al.
Publicado: (2021) -
Identification of LSM family members as potential chemoresistance predictive and therapeutic biomarkers for gastric cancer
por: Liu, Qianhui, et al.
Publicado: (2023) -
Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
por: Zhuang, Hongkai, et al.
Publicado: (2022) -
Up-regulation of L Antigen Family Member 3 Associates With Aggressive Progression of Breast Cancer
por: Dong, Xubin, et al.
Publicado: (2021) -
The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma
por: Feng, Songshan, et al.
Publicado: (2022)